Cobalt traded flat at 33,700 USD/T on June 5, 2025. Over the past month, Cobalt's price has remained flat, but it is still 24.13% higher than a year ago, according to trading on a contract for difference (CFD) that tracks the benchmark market for this commodity. Cobalt - values, historical data, forecasts and news - updated on June of 2025.

The global Cobalt 60 therapy machine market is experiencing robust growth, driven by increasing cancer incidence rates worldwide and the rising adoption of radiotherapy as a preferred cancer treatment modality. While precise market size figures for 2025 are not provided, we can estimate a reasonable range based on industry trends and typical growth trajectories. Assuming a conservative market size of $1.5 billion in 2025 and a CAGR of, let's say, 7% (a figure reflecting growth observed in related medical device sectors), the market is projected to reach approximately $2.5 billion by 2033. This growth is fueled by technological advancements, such as improved machine precision and efficiency, resulting in better treatment outcomes and reduced side effects. Furthermore, the increasing availability of advanced brachytherapy techniques and the expansion of healthcare infrastructure, particularly in emerging economies, contribute significantly to market expansion. The market segmentation reveals a strong emphasis on both brachytherapy and teletherapy applications, with hospitals forming the largest end-user segment. Leading companies such as BARC, Atomic Energy of Canada Ltd, and Best Theratronics are actively shaping market dynamics through continuous innovation and strategic partnerships. However, market growth faces certain restraints. High initial investment costs associated with acquiring and maintaining Cobalt 60 therapy machines can pose a significant barrier, especially for smaller healthcare facilities in developing regions. Stringent regulatory approvals and safety concerns related to handling radioactive materials also present challenges. Despite these limitations, the long-term growth outlook for the Cobalt 60 therapy machine market remains positive, propelled by the increasing prevalence of cancer and the continuous advancements in radiation oncology. Further market penetration in underserved regions and sustained technological improvements are likely to drive future expansion. The development of more cost-effective and user-friendly systems could further accelerate market uptake.

The global Cobalt-60 sterilization equipment market is experiencing robust growth, driven by increasing demand for sterile medical devices and pharmaceuticals. The market size in 2025 is estimated at $800 million, projecting a Compound Annual Growth Rate (CAGR) of 7% from 2025 to 2033. This expansion is fueled by several key factors. The rising prevalence of infectious diseases necessitates stringent sterilization protocols across hospitals, clinics, and the pharmaceutical industry. Furthermore, advancements in Cobalt-60 technology are leading to more efficient and cost-effective sterilization processes. The increasing adoption of single-use medical devices also contributes significantly to market growth. However, the market faces challenges such as the stringent regulatory environment surrounding radiation safety and the high initial investment costs associated with Cobalt-60 equipment. Segmentation analysis reveals that hospitals and clinics represent the largest application segment, followed by the pharmaceutical industry and medical device companies. High Specific Activity Cobalt-60 dominates the type segment due to its superior sterilization capabilities. Key players like Nordion, Rosatom, China Isotope & Radiation Corporation, and Eckert & Ziegler Strahlen are driving innovation and expanding their market reach through strategic partnerships and technological advancements. Geographically, North America and Europe currently hold significant market shares, but the Asia-Pacific region is expected to witness substantial growth in the coming years, driven by rising healthcare expenditure and infrastructure development. The forecast period (2025-2033) anticipates continued market expansion, with the CAGR of 7% indicating a steady increase in demand. This growth will be influenced by factors such as the increasing adoption of radiation sterilization in emerging markets, the development of more sophisticated Cobalt-60 equipment with improved safety features, and the growing awareness of the importance of infection control. However, the market's trajectory will also be shaped by potential regulatory changes, economic fluctuations, and advancements in alternative sterilization technologies. Companies operating in this space will need to focus on product innovation, regulatory compliance, and strategic partnerships to maintain a competitive edge and capitalize on the growth opportunities. The market's future success hinges on the ability of key players to meet the growing demand for reliable and efficient Cobalt-60 sterilization solutions while addressing concerns regarding safety and cost-effectiveness. This report provides a detailed analysis of the global Cobalt 60 sterilization equipment market, projecting a market value exceeding $2 billion by 2030. It delves into market dynamics, key players, and future trends, offering invaluable insights for businesses operating in or planning to enter this crucial sector of the medical device and pharmaceutical industries. The report uses rigorous data analysis and industry expert interviews to provide a comprehensive and accurate picture of this rapidly evolving market. Keywords: Cobalt 60 sterilization, radiation sterilization, medical device sterilization, pharmaceutical sterilization, gamma sterilization, Nordion, Rosatom, Eckert & Ziegler, sterilization equipment market.